NM_021252.5:c.69-130T>A

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_021252.5(RAB18):​c.69-130T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.451 in 758,042 control chromosomes in the GnomAD database, including 80,861 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.43 ( 14648 hom., cov: 32)
Exomes 𝑓: 0.46 ( 66213 hom. )

Consequence

RAB18
NM_021252.5 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.89

Publications

3 publications found
Variant links:
Genes affected
RAB18 (HGNC:14244): (RAB18, member RAS oncogene family) The protein encoded by this gene is a member of a family of Ras-related small GTPases that regulate membrane trafficking in organelles and transport vesicles. Knockdown studies is zebrafish suggest that this protein may have a role in eye and brain development. Mutations in this gene are associated with Warburg micro syndrome type 3. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Jan 2012]
RAB18 Gene-Disease associations (from GenCC):
  • Warburg micro syndrome 3
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • Warburg micro syndrome
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 10-27509745-T-A is Benign according to our data. Variant chr10-27509745-T-A is described in ClinVar as [Benign]. Clinvar id is 668608.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.497 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAB18NM_021252.5 linkc.69-130T>A intron_variant Intron 1 of 6 ENST00000356940.11 NP_067075.1 Q9NP72-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAB18ENST00000356940.11 linkc.69-130T>A intron_variant Intron 1 of 6 1 NM_021252.5 ENSP00000349415.7 Q9NP72-1

Frequencies

GnomAD3 genomes
AF:
0.430
AC:
65274
AN:
151898
Hom.:
14647
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.339
Gnomad AMI
AF:
0.590
Gnomad AMR
AF:
0.382
Gnomad ASJ
AF:
0.569
Gnomad EAS
AF:
0.168
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.489
Gnomad MID
AF:
0.424
Gnomad NFE
AF:
0.502
Gnomad OTH
AF:
0.422
GnomAD4 exome
AF:
0.456
AC:
276249
AN:
606026
Hom.:
66213
AF XY:
0.456
AC XY:
148784
AN XY:
326472
show subpopulations
African (AFR)
AF:
0.337
AC:
5659
AN:
16810
American (AMR)
AF:
0.300
AC:
10521
AN:
35070
Ashkenazi Jewish (ASJ)
AF:
0.567
AC:
11436
AN:
20166
East Asian (EAS)
AF:
0.145
AC:
4784
AN:
33084
South Asian (SAS)
AF:
0.392
AC:
25239
AN:
64388
European-Finnish (FIN)
AF:
0.492
AC:
17927
AN:
36442
Middle Eastern (MID)
AF:
0.462
AC:
1169
AN:
2530
European-Non Finnish (NFE)
AF:
0.506
AC:
184935
AN:
365542
Other (OTH)
AF:
0.456
AC:
14579
AN:
31994
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.512
Heterozygous variant carriers
0
7683
15366
23048
30731
38414
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1640
3280
4920
6560
8200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.429
AC:
65281
AN:
152016
Hom.:
14648
Cov.:
32
AF XY:
0.427
AC XY:
31713
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.338
AC:
14013
AN:
41448
American (AMR)
AF:
0.381
AC:
5825
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.569
AC:
1975
AN:
3472
East Asian (EAS)
AF:
0.167
AC:
868
AN:
5184
South Asian (SAS)
AF:
0.375
AC:
1808
AN:
4818
European-Finnish (FIN)
AF:
0.489
AC:
5163
AN:
10568
Middle Eastern (MID)
AF:
0.432
AC:
127
AN:
294
European-Non Finnish (NFE)
AF:
0.502
AC:
34081
AN:
67934
Other (OTH)
AF:
0.418
AC:
883
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1891
3782
5672
7563
9454
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
604
1208
1812
2416
3020
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.464
Hom.:
2095
Bravo
AF:
0.415
Asia WGS
AF:
0.271
AC:
940
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Benign:1
Jun 19, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.75
CADD
Benign
9.7
DANN
Benign
0.76
PhyloP100
1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11015829; hg19: chr10-27798674; API